Kalwick M, Roth M
Nutrients. 2025; 17(4).
PMID: 40004987
PMC: 11858766.
DOI: 10.3390/nu17040659.
Schuth U, Gill K, Telyuk P, Bawamia B, Austin D, Zaman A
J Clin Med. 2024; 13(21).
PMID: 39518451
PMC: 11546410.
DOI: 10.3390/jcm13216311.
Capra M, Biasucci G, Banderali G, Pederiva C
Int J Mol Sci. 2024; 25(16).
PMID: 39201505
PMC: 11354582.
DOI: 10.3390/ijms25168817.
Aminorroaya A, Dhingra L, Oikonomou E, Saadatagah S, Thangaraj P, Vasisht Shankar S
Nat Cardiovasc Res. 2024; 3(5):558-566.
PMID: 39195936
DOI: 10.1038/s44161-024-00469-1.
Wang T
PLoS One. 2024; 19(5):e0299240.
PMID: 38743736
PMC: 11093325.
DOI: 10.1371/journal.pone.0299240.
Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults.
Yuen T, Mancini G, Hegele R, Pearson G
CJC Open. 2024; 6(3):597-606.
PMID: 38559332
PMC: 10980900.
DOI: 10.1016/j.cjco.2023.11.015.
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization.
Barbieri G, Cassioli G, Kura A, Orsi R, Magi A, Berteotti M
J Clin Lab Anal. 2024; 38(5):e24998.
PMID: 38444303
PMC: 10959181.
DOI: 10.1002/jcla.24998.
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a).
Marlega-Linert J, Gasecka A, van der Pol E, Kuchta A, Filipiak K, Fijalkowski M
Sci Rep. 2024; 14(1):2762.
PMID: 38307884
PMC: 10837138.
DOI: 10.1038/s41598-024-51782-5.
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?.
Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P
Int J Mol Sci. 2023; 24(17).
PMID: 37686169
PMC: 10487946.
DOI: 10.3390/ijms241713363.
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.
Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S
Molecules. 2023; 28(3).
PMID: 36770634
PMC: 9918959.
DOI: 10.3390/molecules28030969.
Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea.
Kim J, Choi S, Lee Y, Lee J, Chung H, Woo J
Ther Clin Risk Manag. 2022; 18:981-987.
PMID: 36212048
PMC: 9533785.
DOI: 10.2147/TCRM.S374372.
The known unknowns of apolipoprotein glycosylation in health and disease.
Subramanian S, Gundry R
iScience. 2022; 25(9):105031.
PMID: 36111253
PMC: 9468411.
DOI: 10.1016/j.isci.2022.105031.
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
Coassin S, Kronenberg F
Atherosclerosis. 2022; 349:17-35.
PMID: 35606073
PMC: 7613587.
DOI: 10.1016/j.atherosclerosis.2022.04.003.
Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area.
Tognetti M, Sklodowski K, Muller S, Kamber D, Muntel J, Bruderer R
J Proteome Res. 2022; 21(7):1718-1735.
PMID: 35605973
PMC: 9251764.
DOI: 10.1021/acs.jproteome.2c00122.
Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus.
Kostner K, Kostner G
Int J Mol Sci. 2022; 23(7).
PMID: 35408941
PMC: 8998850.
DOI: 10.3390/ijms23073584.
Negative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults.
Bie L, Niu J, Wu S, Zheng R, Xu M, Lu J
Front Cardiovasc Med. 2022; 9:800671.
PMID: 35369305
PMC: 8964789.
DOI: 10.3389/fcvm.2022.800671.
Approaches to Visualising Endocytosis of LDL-Related Lipoproteins.
Siddiqui H, Yevstigneyev N, Madani G, McCormick S
Biomolecules. 2022; 12(2).
PMID: 35204658
PMC: 8961563.
DOI: 10.3390/biom12020158.
Lipoprotein(a).
Kronenberg F
Handb Exp Pharmacol. 2021; 270:201-232.
PMID: 34196811
DOI: 10.1007/164_2021_504.
Inflammation and Cardiovascular Disease: The Future.
Arnold N, Lechner K, Waldeyer C, Shapiro M, Koenig W
Eur Cardiol. 2021; 16:e20.
PMID: 34093741
PMC: 8157394.
DOI: 10.15420/ecr.2020.50.
SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies.
Gracia-Rubio I, Martin C, Civeira F, Cenarro A
Biomedicines. 2021; 9(6).
PMID: 34072125
PMC: 8229968.
DOI: 10.3390/biomedicines9060612.